INTERNATIONAL healthcare firm, Abbott will soon be rolling out a revolutionary viral load technological breakthrough the m-PIMA HIV-1/2 VL viral load point-of-care test in Zimbabwe. The turnaround time is only 70 minutes, hence increasing the chances of initiating more people on Anti retro Viral Therapy (ART) and eliminating new transmissions. By Michael Gwarisa The move is in line with UNAIDS 90-90-90 target, where 90 percent of all people living with HIV will know their HIV status and another 90 percent of all people with diagnosed HIV infection will receive sustained…
Read MoreAbbott To Launch Revolutionary Viral Load Testing Technology In Zim
